Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 25, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial

SILVER SPRING, Md., Jan. 25, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes...
January 19, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes

SILVER SPRING, Md., Jan. 19, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
January 14, 2016 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial

SILVER SPRING, Md., Jan. 14, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
January 07, 2016 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference

SILVER SPRING, Md., Jan. 07, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
January 04, 2016 08:45 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial

SILVER SPRING, Md., Jan. 04, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 30, 2015 09:00 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs

SILVER SPRING, Md., Dec. 30, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 15, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Releases New Video Highlighting Diabetes Treatment Development Program

SILVER SPRING, Md., Dec. 15, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 07, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Provides Update on Malignant Ascites and New Colon Cancer Studies

SILVER SPRING, Md., Dec. 07, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
December 04, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Contractor Chamow & Associates to Visit Cell-in-a-Box® Encapsulation Facility in Bangkok, Thailand

SILVER SPRING, Md., Dec. 04, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...
November 24, 2015 09:25 ET | Source: PharmaCyte Biotech, Inc.

PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment

SILVER SPRING, Md., Nov. 24, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and...